Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study.
Ganser A, Lindemann A, Ottmann OG, Seipelt G, Hess U, Geissler G, Kanz L, Frisch J, Schulz G, Herrmann F, et al. Ganser A, et al. Among authors: lindemann a. Blood. 1992 May 15;79(10):2583-91. Blood. 1992. PMID: 1586711 Free article. Clinical Trial.
Results of phase I/II trials with recombinant human interleukin-3.
Ganser A, Ottmann OG, Seipelt G, Eder M, Geissler G, Merget R, Maurer A, Falk S, Lindemann A, Herrmann F, et al. Ganser A, et al. Among authors: lindemann a. Biotechnol Ther. 1991;2(3-4):313-25. Biotechnol Ther. 1991. PMID: 1845133 Review. No abstract available.
Recombinant human interleukin-3 in patients with hematopoietic failure.
Ganser A, Lindemann A, Seipelt G, Ottmann OG, Eder M, Herrmann F, Frisch J, Schulz G, Mertelsmann R, Hoelzer D. Ganser A, et al. Among authors: lindemann a. Recent Results Cancer Res. 1991;121:162-72. doi: 10.1007/978-3-642-84138-5_18. Recent Results Cancer Res. 1991. PMID: 1857856 Clinical Trial.
Biologic effects of recombinant human interleukin-3 in vivo.
Lindemann A, Ganser A, Herrmann F, Frisch J, Seipelt G, Schulz G, Hoelzer D, Mertelsmann R. Lindemann A, et al. J Clin Oncol. 1991 Dec;9(12):2120-7. doi: 10.1200/JCO.1991.9.12.2120. J Clin Oncol. 1991. PMID: 1960553 Clinical Trial.
Clinical effects of recombinant human interleukin-3.
Ganser A, Lindemann A, Seipelt G, Ottmann OG, Herrmann F, Eder M, Frisch J, Schulz G, Mertelsmann R, Hoelzer D. Ganser A, et al. Among authors: lindemann a. Am J Clin Oncol. 1991;14 Suppl 1:S51-63. doi: 10.1097/00000421-199112001-00010. Am J Clin Oncol. 1991. PMID: 2048566 Review.
Effects of recombinant human interleukin-3 in aplastic anemia.
Ganser A, Lindemann A, Seipelt G, Ottmann OG, Eder M, Falk S, Herrmann F, Kaltwasser JP, Meusers P, Klausmann M, et al. Ganser A, et al. Among authors: lindemann a. Blood. 1990 Oct 1;76(7):1287-92. Blood. 1990. PMID: 2207306 Free article.
223 results